Accera
Biotechnology company engaged in the discovery and development of therapeutic drugs for neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Oct 2018.)
Denver Colorado (HQ)
Authorizing premium user...